Enveric Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Enveric Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Enveric Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.9M, a 67% increase year-over-year.
  • Enveric Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$10.2M, a 64.2% increase year-over-year.
  • Enveric Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$16.4M, a 40% increase from 2022.
  • Enveric Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$27.4M, a 57.6% increase from 2021.
  • Enveric Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$64.6M, a 1050% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$10.2M -$1.9M +$3.86M +67% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$14.1M -$2.48M +$2.38M +49% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$16.4M -$2.38M +$9.87M +80.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$26.3M -$3.45M +$2.21M +39% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$28.5M -$5.76M -$1.05M -22.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$27.5M -$4.86M -$64.8K -1.35% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$27.4M -$12.3M +$38.7M +76% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$66.1M -$5.66M -$2.14M -60.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$64M -$4.71M -$1.34M -40% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$62.7M -$4.8M +$1.97M +29.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$64.6M -$51M -$47.5M -1347% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-06-09
Q3 2021 -$17.2M -$3.52M -$3.03M -618% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$14.1M -$3.36M -$2.6M -338% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$11.5M -$6.76M -$5.93M -709% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$5.62M -$3.52M -$5.57M -272% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$50.8K -$490K +$1.08M +68.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.13M -$768K +$709K +48% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$1.83M -$837K +$462K +35.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$2.3M $2.04M +$12.8M Oct 1, 2019 Dec 31, 2019 10-K 2021-04-01
Q3 2019 -$15.1M -$1.57M -$7.67M -126% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$7.47M -$1.48M -$397K -36.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$7.08M -$1.3M +$68.4K +5.01% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$7.15M -$10.8M -$7.99M -284% Oct 1, 2018 Dec 31, 2018 10-K/A 2020-08-12
Q3 2018 $842K $6.1M +$10M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$9.2M -$1.08M +$2.43M +69.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$11.6M -$1.37M -$736K -117% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$10.9M -$2.81M -$642K -29.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 -$10.3M -$3.95M -$2.65M -205% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$7.6M -$3.51M -$2.57M -275% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$5.03M -$631K +$351K +35.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$5.38M -$2.17M -$435K -25.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$4.94M -$1.29M -$976K -309% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$3.97M -$937K -$1.12M -620% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$2.85M -$981K -$2.06M -191% Jan 1, 2016 Mar 31, 2016 10-Q/A 2017-05-15
Q4 2015 -$794K -$1.73M -$1.2M -226% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-04-04
Q3 2015 $409K -$316K -$313K -10043% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $722K $180K -$395K -68.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 $1.12M $1.08M +$1.08M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $32.8K -$532K -$572K -1417% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-31
Q3 2014 $605K -$3.11K +$1.44K +31.7% Jul 1, 2014 Sep 30, 2014 10-Q/A 2014-11-14
Q2 2014 $603K $575K +$579K Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-18
Q1 2014 $24.3K -$7.58K -$2.89K -61.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $27.2K $40.4K +$50.4K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$23.1K -$4.56K +$9.00 +0.2% Jul 1, 2013 Sep 30, 2013 10-Q/A 2014-11-14
Q2 2013 -$23.2K -$3.89K +$190 +4.66% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$23.3K -$4.7K -$653 -16.1% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-08
Q4 2012 -$22.7K -$10K +$3K +23.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-28
Q3 2012 -$25.7K -$4.57K -$879 -23.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 -$24.8K -$4.08K -$450 -12.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 -$24.4K -$4.05K +$7.04K +63.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 -$31.4K -$13K Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 -$3.69K +$1.93K +34.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$3.63K +$845 +18.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 -$11.1K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-05-10
Q3 2010 -$5.61K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.48K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.